TrialAmerican journal of hematology2018

Inhaled corticosteroid use to prevent severe vaso-occlusive episode recurrence in children between 1 and 4 years of age with sickle cell disease: a multicenter feasibility trial.

Leah Vance Utset et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.